Joke Comijn is an experienced professional in the field of communications and engagement within the biotechnology and pharmaceutical sectors. Currently serving as the Director of Site & Patient Engagement at argenx since January 2015, Joke Comijn has been instrumental in developing and executing communication strategies to enhance patient and site engagement across global clinical trials. Previous roles include Director of Corporate Communications & Investor Relations and Owner at Talk bvba, focusing on communication for biotech and pharma companies. Additional experience includes positions in marketing and communications at Cartagenia and Biocartis, among others. Joke Comijn holds a Ph.D. in Biotechnology and a Licentiaat in Biotechnologie from Ghent University.
This person is not in any teams
This person is not in any offices